Thabor Therapeutics
Latest round
- Seed
Last raised
- Jul 2021
Total raised
- $1.2M
Investors
- 1
About Thabor Therapeutics
Based in France, and founded in 2021 by Eric Chevet, Eric Ogier – Denis, and Xavier Treton, Thabor Therapeutics, is the provider of drugs for the cure of human mucosal inflammatory diseases. As of 2022, the company is headed by Jeremie Mariau as CEO. The company develops the treatment of chronic mucosal inflammatory diseases, in particular Inflammatory Bowel Disease (IBD) such as Crohn’s disease and ulcerative colitis.
Who invested in Thabor Therapeutics
1 investor across 1 round
See all investors in Thabor Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 27, 2021
Amount
$1.2M
Investors
Questions about Thabor Therapeutics
Who invested in Thabor Therapeutics?
Thabor Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Thabor Therapeutics raised?
Thabor Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Thabor Therapeutics last raise money?
Thabor Therapeutics's most recent round on record is a Seed, in Jul 2021.
What does Thabor Therapeutics do?
Based in France, and founded in 2021 by Eric Chevet, Eric Ogier – Denis, and Xavier Treton, Thabor Therapeutics, is the provider of drugs for the cure of human mucosal inflammatory diseases.
Where is Thabor Therapeutics headquartered?
Thabor Therapeutics is headquartered in Paris, France.
Which VCs invest in companies like Thabor Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Thabor Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Thabor Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.